|
|
Volumn 61, Issue 5, 1997, Pages 503-508
|
|
Steroid therapy and H2-receptor antagonists: Pharmacoeconomic implications
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
CIMETIDINE;
FAMOTIDINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
MISOPROSTOL;
NIZATIDINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMEPRAZOLE;
RANITIDINE;
STEROID;
SUCRALFATE;
CORTICOSTEROID;
ARTICLE;
CATARACT;
DRUG APPROVAL;
DRUG COST;
DRUG INDICATION;
EDEMA;
ENTERIC COATED TABLET;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL HEMORRHAGE;
HUMAN;
HYPERGLYCEMIA;
HYPERTENSION;
IMMUNE DEFICIENCY;
INHALATIONAL DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
OSTEOPOROSIS;
PEPTIC ULCER;
PRESCRIPTION;
PRIORITY JOURNAL;
PROPHYLAXIS;
RECTAL DRUG ADMINISTRATION;
STEROID THERAPY;
CHEMICALLY INDUCED DISORDER;
DRUG COMBINATION;
ECONOMICS;
INFORMATION PROCESSING;
MEDLINE;
PEPTIC ULCER BLEEDING;
RETROSPECTIVE STUDY;
REVIEW;
RISK FACTOR;
ADRENAL CORTEX HORMONES;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
DATA COLLECTION;
DRUG THERAPY, COMBINATION;
HISTAMINE H2 ANTAGONISTS;
HUMANS;
MEDLINE;
PEPTIC ULCER;
PEPTIC ULCER HEMORRHAGE;
RETROSPECTIVE STUDIES;
RISK FACTORS;
|
|
EID: 0030610699
PISSN: 00099236
EISSN: None
Source Type: Journal
DOI: 10.1016/S0009-9236(97)90130-2 Document Type: Article |
|
Times cited : (6)
|
|
References (18)
|
